Cargando…
Translocation t(11;14) (q13;q32) and genomic imbalances in multi-ethnic multiple myeloma patients: a Malaysian study
More than 50% of myeloma cases have normal karyotypes under conventional cytogenetic analysis due to low mitotic activity and content of plasma cells in the bone marrow. We used a polymerase chain reaction (PCR)-based translocation detection assay to detect BCL1/JH t(11;14) (q13;q32) in 105 myeloma...
Autores principales: | Ni, Ivyna Bong Pau, Ching, Ng Ching, Meng, Chang Kian, Zakaria, Zubaidah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475941/ https://www.ncbi.nlm.nih.gov/pubmed/23087808 http://dx.doi.org/10.4081/hr.2012.e19 |
Ejemplares similares
-
Identification of novel pathogenic copy number aberrations in multiple myeloma: the Malaysian context
por: Ivyna Bong, Pau Ni, et al.
Publicado: (2014) -
Is t(11;14)(q13;q32) good or bad for newly diagnosed multiple myeloma?
por: Liu, Yang, et al.
Publicado: (2023) -
MicroRNA expression patterns and target prediction in multiple myeloma development and malignancy
por: Bong, Ivyna Pau Ni, et al.
Publicado: (2017) -
The CCND1 870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma
por: Weinhold, Niels, et al.
Publicado: (2013) -
Venetoclax in combination with carfilzomib and dexamethasone in relapsed/refractory multiple myeloma harboring t(11,14)(q13;q32): two case reports and a review of the literature
por: Abuelgasim, Khadega A., et al.
Publicado: (2020)